MABXIENCE
LIVE

Serial Number

79414585

Owner

MABXIENCE RESEARCH, S.L.

Attorney

Vivian Ortiz-Ponce

Filing Date

Dec 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MABXIENCE Trademark

Serial Number: 79414585

MABXIENCE is a trademark filed by MABXIENCE RESEARCH, S.L. on December 17, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

MABXIENCE RESEARCH, S.L. (16 trademarks)

C/ Manuel Pombo Angulo, 28 3ª. Planta

Entity Type: 99

Trademark Details

Filing Date

December 17, 2024

Registration Date

Not Registered

Published for Opposition

April 28, 2026

Goods & Services

Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, pharmaceutical preparations for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, genitourinary disorders, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, psychiatric diseases, central nervous system; pharmaceutical preparations for the treatment of diseases of the musculoskeletal system, diseases of the respiratory system, circulatory system, circulatory diseases, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, treatment of the liver, cholesterol, blood pressure and rheumatic treatments; veterinary preparations for treating digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, central nervous system, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments, and dietetic foods adapted for medical use, namely, breads, pastas, crackers, chips, packaged meals, nutritional food bars, candy, dips, sauces and food supplements in pill, powder capsule, beverage form, effervescent tablet and liquid form

Chemical, biological and pharmaceutical research services

Medical and surgical apparatus and instruments, namely, retractors, surgical amputators, surgical robots, surgical drills, medical and surgical knives, surgical staples, surgical scissors, surgical pliers, forceps, surgical saws, clamps for gynecological, ophthalmic, dermatological, metabolic use and respiratory procedures; suture materials

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 8, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 8, 2026 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2026 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2026 COAR
REFUSAL PROCESSED BY IB
Nov 22, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 24, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 24, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 9, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 8, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 7, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 23, 2025 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 9, 2025 SDRC